Adamax 1032 Da (5mg)
Defined 1032 Da Adamantylglycine Research Construct
Adamax 1032 Da is listed for modified-construct evidence limits. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Specified 1032.2 Da identity
- Adamantylglycine terminal modification
- Distinct from 984 Da Adamax
- 5mg lyophilized research vial
What is Adamax 1032 Da?
Adamax 1032 Da is a supplier-specified Semax-family research construct. Its listed structure is Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Adamantylglycine-NH₂. The 1032 Da label describes molecular identity; this catalog item contains 5mg per vial.
Listed vial contents: 5mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
Which identity should I verify?
For this product, verify Ac-MEHFPGP-Adamantylglycine-NH₂, formula C₅₀H₆₉N₁₁O₁₁S and an average molecular mass near 1032.2 Da. The roughly 48 Da difference from the 984 label is the net difference between complete specified molecules, not the mass of a simply added adamantane group. Purity alone does not establish identity or 5mg vial quantity.
What mechanisms are being studied?
The specified molecule combines an N-acetylated Semax-family core with a C-terminal adamantylglycine amide. Adamantane is a cage-shaped hydrocarbon group. P021 researchers used an adamantylglycine modification to investigate stability and brain exposure in a different, CNTF-derived peptide. That design rationale has not been demonstrated for Adamax 1032 Da.
What are the research questions?
- LC-MS identity assignment for the specified 1032.2 Da construct
- Comparisons with the distinct 984 Da non-adamantane construct
- Testing whether the terminal modification changes measured stability or model-specific responses
What does the published work describe?
Semax studies provide background for the parent peptide family. P021 mouse studies provide background for an adamantylglycine design rationale in a different peptide. Neither literature set tests Adamax 1032 Da. No independent peer-reviewed study directly characterizing or comparing the two Adamax constructs was verified for this page.
Experimental models in the cited papers
- Rat hippocampus; parent Semax only
- 3×Tg-AD mouse model; P021 only
What could future research explore?
A defined pharmacokinetic and analytical comparison could test whether the specified terminal modification changes stability, exposure or duration relative to confirmed Semax-family comparators. Those proposed properties should not be treated as established before direct compound-specific data exist.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
Claims that Adamax is stronger, longer acting, more brain-penetrant or clinically beneficial are not supported by direct evidence for this construct. Semax and P021 findings cannot be transferred to Adamax 1032 Da. The listed structure and formula are supplier specifications and require matching batch confirmation.
Study references
- Dolotov OV, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006. DOI 10.1016/j.brainres.2006.07.080
- Baazaoui N, Iqbal K. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound. Alzheimers Res Ther. 2017. DOI 10.1186/s13195-017-0273-7
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Adamax 1032 Da handled in the lab?
For Adamax 1032 Da, record the product code ADAMAX-1032, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Adamax 1032 Da from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For Adamax 1032 Da, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 1032.2 Da as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Adamax 1032 Da form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Adamax 1032 Da laboratory protocol should record identity, product code ADAMAX-1032, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
How do the two Adamax products differ?
The molecular-mass labels identify different specified structures. They are not two strengths of one molecule. Both catalog products contain 5mg per vial.
| Specification | Adamax 984 Da | Adamax 1032 Da |
|---|---|---|
| Specified sequence | Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-OH | Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Adamantylglycine-NH₂ |
| Formula | C₄₄H₆₁N₁₁O₁₃S | C₅₀H₆₉N₁₁O₁₁S |
| Average mass | Approximately 984.1 Da | Approximately 1032.2 Da |
| Terminal chemistry | Ala-Gly extension; free-acid C-terminus | Adamantylglycine; amidated C-terminus |
| Adamantane | No adamantane group in the specified structure | Specified adamantane-based terminal modification |
A high purity result does not by itself identify the construct or establish the quantity in a vial. Match the target sequence, expected mass, observed analytical result, lot and declared 5mg content.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Adamax 1032 Da
- CAS Number
- N/A
- Molecular Weight
- 1032.2 Da
- HPLC Purity Specification
- ≥99%
- Category
- Cognitive
- Starting Price
- $79.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Adamax 1032 Da has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Adamax 1032 Da?
Adamax 1032 Da is listed for modified-construct evidence limits. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Adamax 1032 Da are available?
The catalog lists 5mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Adamax 1032 Da purity results?
Adamax 1032 Da has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Adamax 1032 Da be handled in the laboratory?
For Adamax 1032 Da, record the product code ADAMAX-1032, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Adamax 1032 Da?
Choose a solvent for Adamax 1032 Da from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a Adamax 1032 Da stock concentration?
For Adamax 1032 Da, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 1032.2 Da as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Adamax 1032 Da be stored after preparation?
Use the documented storage conditions for the supplied Adamax 1032 Da form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Adamax 1032 Da lab protocol document?
A Adamax 1032 Da laboratory protocol should record identity, product code ADAMAX-1032, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Adamax 1032 Da product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Adamax 1032 Da lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Adamax 1032 Da for human use?
No. Adamax 1032 Da is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
